Balentine LLC’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9K Hold
654
﹤0.01% 200
2025
Q4
$40.6K Hold
654
﹤0.01% 201
2025
Q3
$39.3K Buy
+654
New +$40K ﹤0.01% 206
2021
Q2
Sell
-282
Closed -$16K 229
2021
Q1
$16K Sell
282
-2,928
-91% -$162K ﹤0.01% 186
2020
Q4
$175K Buy
+3,210
New +$168K 0.01% 132

Other funds holding IHI

Balentine LLC's IHI Position: Q1 2026 in Review

Balentine LLC held its iShares US Medical Devices ETF (IHI) position steady in Q1 2026 at 654 shares worth $34.9K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

Balentine LLC first reported a position in IHI in Q4 2020 and has held it in 5 quarters since. The position peaked at $175K in Q4 2020. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Balentine LLC held 654 shares of iShares US Medical Devices ETF worth $34.9K as of Q1 2026.
  • Balentine LLC left its iShares US Medical Devices ETF share count unchanged in Q1 2026.
  • iShares US Medical Devices ETF made up ﹤0.01% of Balentine LLC's portfolio in Q1 2026, its #200 holding.
  • Balentine LLC first reported a position in iShares US Medical Devices ETF in Q4 2020 and has held it in 5 quarters since.
  • Balentine LLC's iShares US Medical Devices ETF position peaked at $175K in Q4 2020.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Balentine LLC's 13F filing for Q1 2026, filed 24 Apr 2026.